UY36350A - COMPOUND DERIVED FROM PIRAZOL FOR TREATMENT OR PREVENTION OF CHAGAS DISEASE. - Google Patents

COMPOUND DERIVED FROM PIRAZOL FOR TREATMENT OR PREVENTION OF CHAGAS DISEASE.

Info

Publication number
UY36350A
UY36350A UY0001036350A UY36350A UY36350A UY 36350 A UY36350 A UY 36350A UY 0001036350 A UY0001036350 A UY 0001036350A UY 36350 A UY36350 A UY 36350A UY 36350 A UY36350 A UY 36350A
Authority
UY
Uruguay
Prior art keywords
prevention
treatment
pirazol
chagas disease
compound derived
Prior art date
Application number
UY0001036350A
Other languages
Spanish (es)
Inventor
Albane Marie Kessler
Rodriguez Ana
Beth Anne Knapp-Reed
Ignacio Cotillo Torrejon
Imanol Peña Urquiza
Jose Julio Martin
Julio Alonso Padilla
Elban Mark
Terry Vincent Hughes
Lian Yiqian
Adam Kenneth Charnley
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of UY36350A publication Critical patent/UY36350A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El compuesto 3-(benzo[d]tiazol-5-il)-5-(metilamino)-1-(2,2,2,-trifluoroetil)-1H-pirazol-4-carboxamida, que tiene la Fórmula (I):o una de sus sales, composiciones que comprenden el compuesto, su uso en el tratamiento o la prevención de la enfermedad de Chagas, y métodos para su preparación.The compound 3- (benzo [d] thiazol-5-yl) -5- (methylamino) -1- (2,2,2, -trifluoroethyl) -1H-pyrazol-4-carboxamide, which has the Formula (I) : or one of its salts, compositions comprising the compound, its use in the treatment or prevention of Chagas disease, and methods for its preparation.

UY0001036350A 2014-10-10 2015-10-08 COMPOUND DERIVED FROM PIRAZOL FOR TREATMENT OR PREVENTION OF CHAGAS DISEASE. UY36350A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14382386 2014-10-10

Publications (1)

Publication Number Publication Date
UY36350A true UY36350A (en) 2016-06-01

Family

ID=51790658

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036350A UY36350A (en) 2014-10-10 2015-10-08 COMPOUND DERIVED FROM PIRAZOL FOR TREATMENT OR PREVENTION OF CHAGAS DISEASE.

Country Status (3)

Country Link
AR (1) AR102215A1 (en)
UY (1) UY36350A (en)
WO (1) WO2016055607A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions

Also Published As

Publication number Publication date
WO2016055607A1 (en) 2016-04-14
AR102215A1 (en) 2017-02-15

Similar Documents

Publication Publication Date Title
CL2018003135A1 (en) Aromatic derivatives of sulfonamide.
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
CL2018001181A1 (en) Ret inhibitors
CO2017004525A2 (en) Ror-gamma inhibitory dihydropyrrolopyridines
CL2018000542A1 (en) New phenoxymethyl derivatives.
CL2014001793A1 (en) Compounds derived from substituted 1,3,5-triazines and their salts, as inhibitors of mutant idh2; pharmaceutical composition that includes them; and its use for the treatment of cancer.
CR20160418A (en) NEW BICYCLE COMPOUNDS OF 7 LINKS
CL2016001889A1 (en) (2s) -n - [(1s) -1-cyano-2-phenylethyl] -1,4-oxazepan-2-carboxamides as dipeptidyl peptidase 1 inhibitors.
CL2012003415A1 (en) Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
CL2015002860A1 (en) Alpha-v-beta-6 integrin antagonists
CL2013001338A1 (en) Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv.
CL2016002169A1 (en) Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders.
GT201400111A (en) SUBSTITUTED TRIAZOLOPIRIDINS
DOP2016000253A (en) NEW COMPOUNDS
EA201790627A1 (en) STEMULATORS RHC
CL2016000568A1 (en) Compounds derived from substituted 2h-indazol-2-yl-n-hydroxy-2-methylsulfonyl-2-methyl-butanamide or salts thereof; its pharmaceutical compositions containing them and their use for the prevention and / or treatment of gram-negative bacterial infections.
DOP2016000212A (en) CONDENSED HETEROCICLES REPLACED AS MODULATORS OF GPR119 FOR THE TREATMENT OF DIABETES, OBESITY, DISLIPIDEMIA AND RELATED DISORDERS
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
CL2017000014A1 (en) Isondolin derivatives for use in the treatment of a viral infection
DOP2016000312A (en) COMPOUNDS DERIVED FROM 1- (CICLOPENT-2-EN-1-IL) -3- (2-HIDROXI-3- (ARILSULFONIL) PHENYL) UREA AS CXCR2 INHIBITORS
CR20160016A (en) SUBSTITUTED PIRAZOLPIRIDINS
CL2014000393A1 (en) Compounds derived from benzofuran and its salts, as hepatitis c virus inhibitors; pharmaceutical composition that includes them; and its use for the treatment or prevention of an infection with the hepatitis c virus or a disease associated with said infection.
BR112018014590A2 (en) formulations / compositions comprising a btk inhibitor
NI201500175A (en) NEW COMPOUNDS FOR THE TREATMENT OF CANCER
UY36217A (en) PIRIDONA SUBSTITUTE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.